{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:48:29Z","timestamp":1783579709510,"version":"3.55.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,14]]},"DOI":"10.7759\/cureus.37578","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T17:37:46Z","timestamp":1681493866000},"source":"Crossref","is-referenced-by-count":17,"title":["Guillain-Barr\u00e9 Syndrome Induced by Vaccination Against COVID-19: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Olajide Bamidele","family":"Ogunjimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Tsalamandris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Zis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e58","article-title":"Guillain-Barre syndrome after two COVID-19 vaccinations: two case reports with follow-up electrodiagnostic study","volume":"37","author":"Kim JW","year":"2022","unstructured":"Kim JW, Kim YG, Park YC, Choi S, Lee S, Min HJ, Kim MJ. Guillain-Barre syndrome after two COVID-19 vaccinations: two case reports with follow-up electrodiagnostic study. J Korean Med Sci. 2022, 37:e58. 10.3346\/jkms.2022.37.e58","journal-title":"J Korean Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5237","article-title":"Could Guillain-Barr\u00e9 syndrome be triggered by COVID-19 vaccination?","volume":"10","author":"Aldeeb M","year":"2022","unstructured":"Aldeeb M, Okar L, Mahmud SS, Adeli GA. Could Guillain-Barr\u00e9 syndrome be triggered by COVID-19 vaccination?. Clin Case Rep. 2022, 10:e05237. 10.1002\/ccr3.5237","journal-title":"Clin Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"13","author":"Willison HJ","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016, 13:717-27. 10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/793024","article-title":"An update in guillain-barr\u00e9 syndrome","volume":"2014","author":"Winer JB","year":"2014","unstructured":"Winer JB. An update in guillain-barr\u00e9 syndrome. Autoimmune Dis. 2014, 2014:793024. 10.1155\/2014\/793024","journal-title":"Autoimmune Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard SE","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FA, et al.. Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019, 15:671-83. 10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18153","article-title":"A rare variant of Guillain-Barre syndrome following Ad26.COV2.S vaccination","volume":"13","author":"Morehouse ZP","year":"2021","unstructured":"Morehouse ZP, Paulus A, Jasti SA, Bing X. A rare variant of Guillain-Barre syndrome following Ad26.COV2.S vaccination. Cureus. 2021, 13:e18153. 10.7759\/cureus.18153","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder P","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008, 9:559. 10.1186\/1471-2105-9-559","journal-title":"BMC Bioinformatics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins JP","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21:1539-58. 10.1002\/sim.1186","journal-title":"Stat Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01644-8","article-title":"Publisher correction: Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone M","year":"2021","unstructured":"Patone M, Handunnetthi L, Saatci D, et al.. Publisher correction: Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021, 27:2249. 10.1038\/s41591-021-01644-8","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26143","article-title":"Guillain-Barr\u00e9 syndrome following ChAdOx1-S\/nCoV-19 vaccine","volume":"90","author":"Maramattom BV","year":"2021","unstructured":"Maramattom BV, Krishnan P, Paul R, Padmanabhan S, Nampoothiri SCV, Syed AA, Mangat HS. Guillain-Barr\u00e9 syndrome following ChAdOx1-S\/nCoV-19 vaccine. Ann Neurol. 2021, 90:312-4. 10.1002\/ana.26143","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26218","article-title":"Guillain-Barr\u00e9 syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines","volume":"90","author":"Osowicki J","year":"2021","unstructured":"Osowicki J, Morgan H, Harris A, Crawford NW, Buttery JP, Kiers L. Guillain-Barr\u00e9 syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines. Ann Neurol. 2021, 90:856-8. 10.1002\/ana.26218","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05776-0","article-title":"Miller Fisher syndrome following Pfizer COVID-19 vaccine","volume":"43","author":"Abi\u010di\u0107 A","year":"2022","unstructured":"Abi\u010di\u0107 A, Adamec I, Habek M. Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurol Sci. 2022, 43:1495-7. 10.1007\/s10072-021-05776-0","journal-title":"Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26144","article-title":"Guillain-Barr\u00e9 syndrome variant occurring after SARS-CoV-2 vaccination","volume":"90","author":"Allen CM","year":"2021","unstructured":"Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R, Evans JR. Guillain-Barr\u00e9 syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol. 2021, 90:315-8. 10.1002\/ana.26144","journal-title":"Ann Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-05982-4","article-title":"Bilateral facial palsy after COVID-19 vaccination","volume":"43","author":"Andreozzi V","year":"2022","unstructured":"Andreozzi V, D'arco B, Pagliano P, Toriello A, Barone P. Bilateral facial palsy after COVID-19 vaccination. Neurol Sci. 2022, 43:4069-79. 10.1007\/s10072-022-05982-4","journal-title":"Neurol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5733","article-title":"Guillain-Barr\u00e9 syndrome after mRNA-1273 (Moderna) COVID-19 vaccination: a case report","volume":"10","author":"Anjum Z","year":"2022","unstructured":"Anjum Z, Iyer C, Naz S, et al.. Guillain-Barr\u00e9 syndrome after mRNA-1273 (Moderna) COVID-19 vaccination: a case report. Clin Case Rep. 2022, 10:e05733. 10.1002\/ccr3.5733","journal-title":"Clin Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12691\/ajmcr-9-8-10","article-title":"Guillain-Barr\u00e9 syndrome in a 67-year-old male post COVID-19 vaccination (Astra Zeneca)","volume":"9","author":"Azam S","year":"2021","unstructured":"Azam S, Khalil A, Taha A. Guillain-Barr\u00e9 syndrome in a 67-year-old male post COVID-19 vaccination (Astra Zeneca). Am J Med Case Reports. 2021, 9:424-7. 10.12691\/ajmcr-9-8-10","journal-title":"Am J Med Case Reports"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000383","article-title":"Clinical variant of Guillain-Barre syndrome with prominent facial diplegia after AstraZeneca coronavirus disease 2019 vaccine","volume":"23","author":"Badoiu A","year":"2021","unstructured":"Badoiu A, Moranne O, Coudray S, Ion IM. Clinical variant of Guillain-Barre syndrome with prominent facial diplegia after AstraZeneca coronavirus disease 2019 vaccine. J Clin Neuromuscul Dis. 2021, 23:115-6. 10.1097\/CND.0000000000000383","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01798-9","article-title":"Guillain-Barr\u00e9 syndrome following Covid-19 immunization: a report of two cases","volume":"122","author":"Bax F","year":"2022","unstructured":"Bax F, Gigli GL, Belgrado E, Brunelli L, Valente M. Guillain-Barr\u00e9 syndrome following Covid-19 immunization: a report of two cases. Acta Neurol Belg. 2022, 122:1365-7. 10.1007\/s13760-021-01798-9","journal-title":"Acta Neurol Belg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000397","article-title":"Pfizer mRNA COVID-19 vaccination and acute inflammatory demyelinating polyneuropathy","volume":"23","author":"Bernardo KA","year":"2022","unstructured":"Bernardo KA, Misra A. Pfizer mRNA COVID-19 vaccination and acute inflammatory demyelinating polyneuropathy. J Clin Neuromuscul Dis. 2022, 23:230-1. 10.1097\/CND.0000000000000397","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-249749","article-title":"Rare occurrence of Guillain-Barr\u00e9 syndrome after Moderna vaccine","volume":"15","author":"Bijoy George T","year":"2022","unstructured":"Bijoy George T, Kainat A, Pachika PS, Arnold J. Rare occurrence of Guillain-Barr\u00e9 syndrome after Moderna vaccine. BMJ Case Rep. 2022, 15:249749. 10.1136\/bcr-2022-249749","journal-title":"BMJ Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327027","article-title":"Bilateral facial weakness with paresthesia variant of Guillain-Barr\u00e9 syndrome following Vaxzevria COVID-19 vaccine","volume":"93","author":"Bonifacio GB","year":"2022","unstructured":"Bonifacio GB, Patel D, Cook S, et al.. Bilateral facial weakness with paresthesia variant of Guillain-Barr\u00e9 syndrome following Vaxzevria COVID-19 vaccine. J Neurol Neurosurg Psychiatry. 2022, 93:341-2. 10.1136\/jnnp-2021-327027","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05733-x","article-title":"Guillain-Barr\u00e9 syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases","volume":"43","author":"Bouattour N","year":"2022","unstructured":"Bouattour N, Hdiji O, Sakka S, et al.. Guillain-Barr\u00e9 syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurol Sci. 2022, 43:755-61. 10.1007\/s10072-021-05733-x","journal-title":"Neurol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24252","article-title":"Neurologic sequela of COVID-19: Guillain-Barr\u00e9 syndrome following Johnson & Johnson COVID-19 vaccination","volume":"14","author":"Carranza O","year":"2022","unstructured":"Carranza O, Babici D, Waheed S, Yousuf F. Neurologic sequela of COVID-19: Guillain-Barr\u00e9 syndrome following Johnson & Johnson COVID-19 vaccination. Cureus. 2022, 14:e24252. 10.7759\/cureus.24252","journal-title":"Cureus"},{"key":"ref24","article-title":"Guillian Barr\u00e9 syndromeafter mRNA-1273 vaccination against COVID-19 (Article in Danish)","volume":"183","author":"Christensen SK","year":"2021","unstructured":"Christensen SK, Ballegaard M, Boesen MS. Guillian Barr\u00e9 syndromeafter mRNA-1273 vaccination against COVID-19 (Article in Danish). Ugeskr Laeger. 2021, 183:V05210455.","journal-title":"Ugeskr Laeger"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00416-6","article-title":"Guillain-Barr\u00e9 syndrome after vaccination against COVID-19","volume":"21","author":"Chun JY","year":"2022","unstructured":"Chun JY, Park S, Jung J, et al.. Guillain-Barr\u00e9 syndrome after vaccination against COVID-19. Lancet Neurol. 2022, 21:117-9. 10.1016\/S1474-4422(21)00416-6","journal-title":"Lancet Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2021.492","article-title":"Variant Guillain-Barre syndrome following SARS-CoV-2 vaccination: case report and review of the literature","volume":"50","author":"Donaldson L","year":"2023","unstructured":"Donaldson L, Margolin E. Variant Guillain-Barre syndrome following SARS-CoV-2 vaccination: case report and review of the literature. Can J Neurol Sci. 2023, 50:138-40. 10.1017\/cjn.2021.492","journal-title":"Can J Neurol Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18291","article-title":"Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine","volume":"13","author":"Dalwadi V","year":"2021","unstructured":"Dalwadi V, Hancock D, Ballout AA, Geraci A. Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine. Cureus. 2021, 13:e18291. 10.7759\/cureus.18291","journal-title":"Cureus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246701","article-title":"Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination","volume":"14","author":"Dang YL","year":"2021","unstructured":"Dang YL, Bryson A. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Rep. 2021, 14:246701. 10.1136\/bcr-2021-246701","journal-title":"BMJ Case Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120231","article-title":"Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course","volume":"436","author":"de Souza A","year":"2022","unstructured":"de Souza A, Oo WM, Giri P. Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course. J Neurol Sci. 2022, 436:120231. 10.1016\/j.jns.2022.120231","journal-title":"J Neurol Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3619131","article-title":"Exacerbating Guillain-Barr\u00e9 syndrome eight days after vector-based COVID-19 vaccination","volume":"2021","author":"Finsterer J","year":"2021","unstructured":"Finsterer J. Exacerbating Guillain-Barr\u00e9 syndrome eight days after vector-based COVID-19 vaccination. Case Rep Infect Dis. 2021, 2021:3619131. 10.1155\/2021\/3619131","journal-title":"Case Rep Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4081\/ejtm.2022.10111","article-title":"Consider differentials before diagnosing COVID-19 associated polyradiculitis","volume":"32","author":"Finsterer J","year":"2022","unstructured":"Finsterer J, Scorza FA, Scorza CA, Fiorini AC. Consider differentials before diagnosing COVID-19 associated polyradiculitis. Eur J Transl Myol. 2022, 32:10.4081\/ejtm.2022.10111","journal-title":"Eur J Transl Myol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab296","article-title":"A case of sensory ataxic Guillain-Barr\u00e9 syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer)","volume":"115","author":"Fukushima T","year":"2022","unstructured":"Fukushima T, Tomita M, Ikeda S, Hattori N. A case of sensory ataxic Guillain-Barr\u00e9 syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). QJM. 2022, 115:25-7. 10.1093\/qjmed\/hcab296","journal-title":"QJM"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243629","article-title":"Case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccine","volume":"14","author":"Hasan T","year":"2021","unstructured":"Hasan T, Khan M, Khan F, Hamza G. Case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccine. BMJ Case Rep. 2021, 14:243629. 10.1136\/bcr-2021-243629","journal-title":"BMJ Case Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/lt.26279","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 mRNA vaccination in a liver transplantation recipient with favorable treatment response","volume":"28","author":"Hughes DL","year":"2022","unstructured":"Hughes DL, Brunn JA, Jacobs J, Todd PK, Askari FK, Fontana RJ. Guillain-Barr\u00e9 syndrome after COVID-19 mRNA vaccination in a liver transplantation recipient with favorable treatment response. Liver Transpl. 2022, 28:134-7. 10.1002\/lt.26279","journal-title":"Liver Transpl"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106887","article-title":"Guillain-Barr\u00e9\u00a0syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?","volume":"208","author":"Introna A","year":"2021","unstructured":"Introna A, Caputo F, Santoro C, Guerra T, Ucci M, Mezzapesa DM, Trojano M. Guillain-Barr\u00e9\u00a0syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?. Clin Neurol Neurosurg. 2021, 208:106887. 10.1016\/j.clineuro.2021.106887","journal-title":"Clin Neurol Neurosurg"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16612","article-title":"Facial diplegia: a rare, atypical variant of Guillain-Barr\u00e9 syndrome and Ad26.COV2.S vaccine","volume":"13","author":"Jain E","year":"2021","unstructured":"Jain E, Pandav K, Regmi P, Michel G, Altshuler I. Facial diplegia: a rare, atypical variant of Guillain-Barr\u00e9 syndrome and Ad26.COV2.S vaccine. Cureus. 2021, 13:e16612. 10.7759\/cureus.16612","journal-title":"Cureus"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/ncn3.12537","article-title":"Guillain-Barr\u00e9 syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: a case series","volume":"9","author":"James J","year":"2021","unstructured":"James J, Jose J, Gafoor VA, Smita B, Balaram N. Guillain-Barr\u00e9 syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: a case series. Neurol Clin Neurosci. 2021, 9:402-5. 10.1111\/ncn3.12537","journal-title":"Neurol Clin Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244527","article-title":"Guillain-Barr\u00e9 syndrome presenting with facial diplegia following COVID-19 vaccination in two patients","volume":"14","author":"Kanabar G","year":"2021","unstructured":"Kanabar G, Wilkinson P. Guillain-Barr\u00e9 syndrome presenting with facial diplegia following COVID-19 vaccination in two patients. BMJ Case Rep. 2021, 14:244527. 10.1136\/bcr-2021-244527","journal-title":"BMJ Case Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.32598\/bcn.2021.3565.1","article-title":"Guillain-Barre syndrome and COVID-19 vaccine: a report of nine patients","volume":"12","author":"Karimi N","year":"2021","unstructured":"Karimi N, Boostani R, Fatehi F, et al.. Guillain-Barre syndrome and COVID-19 vaccine: a report of nine patients. Basic Clin Neurosci. 2021, 12:703-10. 10.32598\/bcn.2021.3565.1","journal-title":"Basic Clin Neurosci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.33314\/jnhrc.v19i04.3803","article-title":"Post COVID-19 vaccine Guillain-Barr\u00e9 syndrome","volume":"19","author":"Khadka B","year":"2022","unstructured":"Khadka B, Khanal K. Post COVID-19 vaccine Guillain-Barr\u00e9 syndrome. J Nepal Health Res Counc. 2022, 19:852-4. 10.33314\/jnhrc.v19i04.3803","journal-title":"J Nepal Health Res Counc"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.820723","article-title":"Guillain-Barr\u00e9 syndrome and variants following COVID-19 vaccination: report of 13 cases","volume":"12","author":"Kim JE","year":"2021","unstructured":"Kim JE, Min YG, Shin JY, Kwon YN, Bae JS, Sung JJ, Hong YH. Guillain-Barr\u00e9 syndrome and variants following COVID-19 vaccination: report of 13 cases. Front Neurol. 2021, 12:820723. 10.3389\/fneur.2021.820723","journal-title":"Front Neurol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05849-0","article-title":"Guillain-Barr\u00e9 syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea","volume":"43","author":"Kim N","year":"2022","unstructured":"Kim N, Kim JH, Park JS. Guillain-Barr\u00e9 syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea. Neurol Sci. 2022, 43:1491-3. 10.1007\/s10072-021-05849-0","journal-title":"Neurol Sci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002797","article-title":"A rare case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccination","volume":"8","author":"Kripalani Y","year":"2021","unstructured":"Kripalani Y, Lakkappan V, Parulekar L, Shaikh A, Singh R, Vyas P. A rare case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccination. Eur J Case Rep Intern Med. 2021, 8:002707. 10.12890\/2021_002797","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1177\/19418744211065242","article-title":"Guillain-Barr\u00e9 syndrome with rapid onset and autonomic dysfunction following first dose of Pfizer-BioNTech COVID-19 vaccine: a case report","volume":"12","author":"Lanman TA","year":"2022","unstructured":"Lanman TA, Wu C, Cheung H, Goyal N, Greene M. Guillain-Barr\u00e9 syndrome with rapid onset and autonomic dysfunction following first dose of Pfizer-BioNTech COVID-19 vaccine: a case report. Neurohospitalist. 2022, 12:388-90. 10.1177\/19418744211065242","journal-title":"Neurohospitalist"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.210947","article-title":"Guillain-Barr\u00e9 syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barr\u00e9 syndrome","volume":"193","author":"Ling L","year":"2021","unstructured":"Ling L, Bagshaw SM, Villeneuve PM. Guillain-Barr\u00e9 syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barr\u00e9 syndrome. CMAJ. 2021, 193:E1766-9. 10.1503\/cmaj.210947","journal-title":"CMAJ"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X221100876","article-title":"Guillain-Barr\u00e9 syndrome following coronavirus disease vaccine: first report from Nepal","volume":"10","author":"Luitel P","year":"2022","unstructured":"Luitel P, Poudel B, Upadhyay D, et al.. Guillain-Barr\u00e9 syndrome following coronavirus disease vaccine: first report from Nepal. SAGE Open Med Case Rep. 2022, 10:2050313X221100876. 10.1177\/2050313X221100876","journal-title":"SAGE Open Med Case Rep"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01838-4","article-title":"Guillain-Barr\u00e8 syndrome following COVID-19 vaccine mRNA-1273: a case report","volume":"122","author":"Masuccio FG","year":"2022","unstructured":"Masuccio FG, Comi C, Solaro C. Guillain-Barr\u00e8 syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurol Belg. 2022, 122:1369-71. 10.1007\/s13760-021-01838-4","journal-title":"Acta Neurol Belg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4756","article-title":"COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect","volume":"9","author":"Matarneh AS","year":"2021","unstructured":"Matarneh AS, Al-Battah AH, Farooqui K, Ghamoodi M, Alhatou M. COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect. Clin Case Rep. 2021, 9:e04756. 10.1002\/ccr3.4756","journal-title":"Clin Case Rep"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244125","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 vaccination","volume":"14","author":"McKean N","year":"2021","unstructured":"McKean N, Chircop C. Guillain-Barr\u00e9 syndrome after COVID-19 vaccination. BMJ Case Rep. 2021, 14:244125. 10.1136\/bcr-2021-244125","journal-title":"BMJ Case Rep"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577691","article-title":"Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: report of two cases and review of literature","volume":"359","author":"Min YG","year":"2021","unstructured":"Min YG, Ju W, Ha YE, Ban JJ, Lee SA, Sung JJ, Shin JY. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: report of two cases and review of literature. J Neuroimmunol. 2021, 359:577691. 10.1016\/j.jneuroim.2021.577691","journal-title":"J Neuroimmunol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011881","article-title":"Guillain- Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality [PREPRINT]","volume":"10","author":"M\u00e1rquez Loza AM","year":"2021","unstructured":"M\u00e1rquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain- Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality [PREPRINT]. Neurology. 2021, 10:10.1212\/WNL.0000000000011881","journal-title":"Neurology"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-022-01124-1","article-title":"Sub-acute Onset of Guillain-Barr\u00e9 Syndrome post-mRNA-1273 vaccination: a case report","volume":"4","author":"Nagalli S","year":"2022","unstructured":"Nagalli S, Shankar Kikkeri N. Sub-acute Onset of Guillain-Barr\u00e9 Syndrome post-mRNA-1273 vaccination: a case report. SN Compr Clin Med. 2022, 4:41. 10.1007\/s42399-022-01124-1","journal-title":"SN Compr Clin Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05467-w","article-title":"A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine","volume":"42","author":"Nasuelli NA","year":"2021","unstructured":"Nasuelli NA, De Marchi F, Cecchin M, et al.. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurol Sci. 2021, 42:4747-9. 10.1007\/s10072-021-05467-w","journal-title":"Neurol Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02489-x","article-title":"Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination","volume":"21","author":"Nishiguchi Y","year":"2021","unstructured":"Nishiguchi Y, Matsuyama H, Maeda K, Shindo A, Tomimoto H. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC Neurol. 2021, 21:452. 10.1186\/s12883-021-02489-x","journal-title":"BMC Neurol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8967-21","article-title":"Sensory ataxic Guillain-Barr\u00e9 syndrome with dysgeusia after mRNA COVID-19 vaccination","volume":"61","author":"Ogata S","year":"2022","unstructured":"Ogata S, Ishii Y, Asano K, et al.. Sensory ataxic Guillain-Barr\u00e9 syndrome with dysgeusia after mRNA COVID-19 vaccination. Intern Med. 2022, 61:1757-60. 10.2169\/internalmedicine.8967-21","journal-title":"Intern Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2021.e01143","article-title":"Guillain-Barr\u00e9 syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association","volume":"24","author":"Ogbebor O","year":"2021","unstructured":"Ogbebor O, Seth H, Min Z, Bhanot N. Guillain-Barr\u00e9 syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases. 2021, 24:e01143. 10.1016\/j.idcr.2021.e01143","journal-title":"IDCases"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.4103\/ijph.ijph_1716_21","article-title":"Post coronavirus disease-2019 vaccination Guillain-Barr\u00e9 syndrome","volume":"65","author":"Biswas A","year":"2021","unstructured":"Biswas A, Pandey SK, Kumar D, Vardhan H. Post coronavirus disease-2019 vaccination Guillain-Barr\u00e9 syndrome. Indian J Public Health. 2021, 65:422-4. 10.4103\/ijph.ijph_1716_21","journal-title":"Indian J Public Health"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242956","article-title":"Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1","volume":"14","author":"Patel SU","year":"2021","unstructured":"Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021, 14:242956. 10.1136\/bcr-2021-242956","journal-title":"BMJ Case Rep"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint13030040","article-title":"A novel case of bifacial diplegia variant of Guillain-Barr\u00e9 syndrome following Janssen COVID-19 vaccination","volume":"13","author":"Prasad A","year":"2021","unstructured":"Prasad A, Hurlburt G, Podury S, Tandon M, Kingree S, Sriwastava S. A novel case of bifacial diplegia variant of Guillain-Barr\u00e9 syndrome following Janssen COVID-19 vaccination. Neurol Int. 2021, 13:404-9. 10.3390\/neurolint13030040","journal-title":"Neurol Int"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2021.1954284","article-title":"A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine","volume":"11","author":"Rao SJ","year":"2021","unstructured":"Rao SJ, Khurana S, Murthy G, Dawson ET, Jazebi N, Haas CJ. A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine. J Community Hosp Intern Med Perspect. 2021, 11:597-600. 10.1080\/20009666.2021.1954284","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102540","article-title":"Post-COVID-19 vaccine Guillain-Barr\u00e9 syndrome; first reported case from Qatar","volume":"67","author":"Razok A","year":"2021","unstructured":"Razok A, Shams A, Almeer A, Zahid M. Post-COVID-19 vaccine Guillain-Barr\u00e9 syndrome; first reported case from Qatar. Ann Med Surg (Lond). 2021, 67:102540. 10.1016\/j.amsu.2021.102540","journal-title":"Ann Med Surg (Lond)"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2021.07.062","article-title":"Guillain-Barr\u00e9 syndrome presenting as facial diplegia after Covid-19 vaccination: a case report","volume":"61","author":"Rossetti A","year":"2021","unstructured":"Rossetti A, Gheihman G, O'Hare M, Kosowsky JM. Guillain-Barr\u00e9 syndrome presenting as facial diplegia after Covid-19 vaccination: a case report. J Emerg Med. 2021, 61:e141-5. 10.1016\/j.jemermed.2021.07.062","journal-title":"J Emerg Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1954826","article-title":"Electromyoneurography and laboratory findings in a case of Guillain-Barr\u00e9 syndrome after second dose of Pfizer COVID-19 vaccine","volume":"17","author":"Scendoni R","year":"2021","unstructured":"Scendoni R, Petrelli C, Scaloni G, Logullo FO. Electromyoneurography and laboratory findings in a case of Guillain-Barr\u00e9 syndrome after second dose of Pfizer COVID-19 vaccine. Hum Vaccin Immunother. 2021, 17:4093-6. 10.1080\/21645515.2021.1954826","journal-title":"Hum Vaccin Immunother"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029333","article-title":"Miller Fisher syndrome after COVID-19 vaccination: case report and review of literature","volume":"101","author":"Siddiqi AR","year":"2022","unstructured":"Siddiqi AR, Khan T, Tahir MJ, Asghar MS, Islam MS, Yousaf Z. Miller Fisher syndrome after COVID-19 vaccination: case report and review of literature. Medicine (Baltimore). 2022, 101:e29333. 10.1097\/MD.0000000000029333","journal-title":"Medicine (Baltimore)"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12678","article-title":"Guillain-Barr\u00e9 syndrome after coronavirus disease 2019 vaccine: a temporal association","volume":"13","author":"da Silva GF","year":"2022","unstructured":"da Silva GF, da Silva CF, Oliveira RE, et al.. Guillain-Barr\u00e9 syndrome after coronavirus disease 2019 vaccine: a temporal association. Clin Exp Neuroimmunol. 2022, 13:92-4. 10.1111\/cen3.12678","journal-title":"Clin Exp Neuroimmunol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.vacun.2022.02.002","article-title":"Case report of Guillain-Barr\u00e9 Syndrome after COVID BNT162b2 mRNA vaccine (Article in Spanish)","volume":"23","author":"Sosa-Hern\u00e1ndez O","year":"2022","unstructured":"Sosa-Hern\u00e1ndez O, S\u00e1nchez-Cardoza S. Case report of Guillain-Barr\u00e9 Syndrome after COVID BNT162b2 mRNA vaccine (Article in Spanish). Vacunas. 2022, 23:68-70. 10.1016\/j.vacun.2022.02.002","journal-title":"Vacunas"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-022-00172-1","article-title":"Guillain-Barr\u00e9 syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy","volume":"4","author":"Stefanou MI","year":"2022","unstructured":"Stefanou MI, Karachaliou E, Chondrogianni M, et al.. Guillain-Barr\u00e9 syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy. Neurol Res Pract. 2022, 4:6. 10.1186\/s42466-022-00172-1","journal-title":"Neurol Res Pract"},{"key":"ref68","article-title":"The first Guillain-Barr? Syndrome after SARS-CoV-2 vaccination in Taiwan","volume":"31(1)","author":"Su SC","year":"2022","unstructured":"Su SC, Lyu RK, Chang CW, Tseng WJ. The first Guillain-Barr? Syndrome after SARS-CoV-2 vaccination in Taiwan. Acta Neurol Taiwan. 2022, 31(1):46-51.","journal-title":"Acta Neurol Taiwan"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2045153","article-title":"Post COVID-19 vaccination Guillain-Barre syndrome: three cases","volume":"18","author":"Tabatabaee S","year":"2022","unstructured":"Tabatabaee S, Rezania F, Alwedaie SM, Malekdar E, Badi Z, Tabatabaei SM, Mirzaasgari Z. Post COVID-19 vaccination Guillain-Barre syndrome: three cases. Hum Vaccin Immunother. 2022, 18:2045153. 10.1080\/21645515.2022.2045153","journal-title":"Hum Vaccin Immunother"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.935275","article-title":"Guillain-Barr\u00e9 syndrome after Ad26.COV2.S vaccination","volume":"23","author":"Thant HL","year":"2022","unstructured":"Thant HL, Morgan R, Paese MM, Persaud T, Diaz J, Hurtado L. Guillain-Barr\u00e9 syndrome after Ad26.COV2.S vaccination. Am J Case Rep. 2022, 23:e935275. 10.12659\/AJCR.935275","journal-title":"Am J Case Rep"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2021.04.005","article-title":"Guillain-Barr\u00e9 syndrome following first injection of ChAdOx1 nCoV-19 vaccine: first report","volume":"177","author":"Theuriet J","year":"2021","unstructured":"Theuriet J, Richard C, Becker J, Pegat A, Bernard E, Vukusic S. Guillain-Barr\u00e9 syndrome following first injection of ChAdOx1 nCoV-19 vaccine: first report. Rev Neurol (Paris). 2021, 177:1305-7. 10.1016\/j.neurol.2021.04.005","journal-title":"Rev Neurol (Paris)"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05523-5","article-title":"Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine","volume":"42","author":"Trimboli M","year":"2021","unstructured":"Trimboli M, Zoleo P, Arabia G, Gambardella A. Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine. Neurol Sci. 2021, 42:4401-2. 10.1007\/s10072-021-05523-5","journal-title":"Neurol Sci"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.18071\/isz.74.0286","article-title":"A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN","volume":"74","author":"Tutar NK","year":"2021","unstructured":"Tutar NK, Eyig\u00fcrb\u00fcz T, Yildirim Z, Kale N. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogy Sz. 2021, 74:286-8. 10.18071\/isz.74.0286","journal-title":"Ideggyogy Sz"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13426","article-title":"Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine","volume":"13","author":"Waheed S","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021, 13:e13426. 10.7759\/cureus.13426","journal-title":"Cureus"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8851-21","article-title":"Miller Fisher syndrome following vaccination against SARS-CoV-2","volume":"61","author":"Yamakawa M","year":"2022","unstructured":"Yamakawa M, Nakahara K, Nakanishi T, Nomura T, Ueda M. Miller Fisher syndrome following vaccination against SARS-CoV-2. Intern Med. 2022, 61:1067-9. 10.2169\/internalmedicine.8851-21","journal-title":"Intern Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22341","article-title":"Facial diplegia variant of Guillain-Barr\u00e9 syndrome in pregnancy following COVID-19 vaccination: a case report","volume":"14","author":"Zubair AS","year":"2022","unstructured":"Zubair AS, Bae JY, Desai K. Facial diplegia variant of Guillain-Barr\u00e9 syndrome in pregnancy following COVID-19 vaccination: a case report. Cureus. 2022, 14:e22341. 10.7759\/cureus.22341","journal-title":"Cureus"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15497","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19: a 1-year observational multicenter study","volume":"29","author":"Filosto M","year":"2022","unstructured":"Filosto M, Cotti Piccinelli S, Gazzina S, et al.. Guillain-Barr\u00e9 syndrome and COVID-19: a 1-year observational multicenter study. Eur J Neurol. 2022, 29:3358-67. 10.1111\/ene.15497","journal-title":"Eur J Neurol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12209","article-title":"International Guillain-Barr\u00e9 Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barr\u00e9 syndrome","volume":"22","author":"Jacobs BC","year":"2017","unstructured":"Jacobs BC, van den Berg B, Verboon C, et al.. International Guillain-Barr\u00e9 Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barr\u00e9 syndrome. J Peripher Nerv Syst. 2017, 22:68-76. 10.1111\/jns.12209","journal-title":"J Peripher Nerv Syst"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/147488-guillain-barr-syndrome-induced-by-vaccination-against-covid-19-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:42Z","timestamp":1707508722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/147488-guillain-barr-syndrome-induced-by-vaccination-against-covid-19-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":78,"URL":"https:\/\/doi.org\/10.7759\/cureus.37578","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}